Restless legs syndrome: Difference between revisions

Jump to navigation Jump to search
Line 36: Line 36:


==Treatment==
==Treatment==
[[Restless legs syndrome medical therapy|Medical Therapy]] | [[Restless legs syndrome surgery | Surgery]] | [[Restless legs syndrome primary prevention|Primary Prevention]] | [[Restless legs syndrome secondary prevention|Secondary Prevention]] | [[Restless legs syndrome cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Restless legs syndrome future or investigational therapies|Future or Investigational Therapies]]
===Medical Therapy===  
===Medical Therapy===  
See potential causal relationship between acidosis and RLS above in "Explanation." An algorithm for treating Primary RLS ( RLS without any secondary medical condition including [[Iron deficiency (medicine)|iron deficiency]], [[varicose vein]], [[thyroid]], etc.) was created by leading RLS researchers at the [[Mayo Clinic]] and is endorsed by the Restless Legs Syndrome Foundation. This document provides guidance to both the treating physician and the patient, and includes both nonpharmacological and pharmacological treatments.<ref name="MayoAlgo">[http://www.mayoclinicproceedings.com/inside.asp?AID=1698&UID Mayo Clinic Algorithm] also available [http://www.mayoclinicproceedings.com/pdf/7907/7907crc.pdf as .pdf]</ref> Treatment of primary RLS should not be considered unless all the secondary medical conditions are ruled out. Drug therapy in RLS is not curative and is  known to have significant side effects and needs to be considered with caution. The secondary form of RLS has the potential for cure if the  precipitating medical condition ([[iron deficiency]], venous reflux/[[varicose vein]], [[thyroid]], etc.) is managed effectively.
See potential causal relationship between acidosis and RLS above in "Explanation." An algorithm for treating Primary RLS ( RLS without any secondary medical condition including [[Iron deficiency (medicine)|iron deficiency]], [[varicose vein]], [[thyroid]], etc.) was created by leading RLS researchers at the [[Mayo Clinic]] and is endorsed by the Restless Legs Syndrome Foundation. This document provides guidance to both the treating physician and the patient, and includes both nonpharmacological and pharmacological treatments.<ref name="MayoAlgo">[http://www.mayoclinicproceedings.com/inside.asp?AID=1698&UID Mayo Clinic Algorithm] also available [http://www.mayoclinicproceedings.com/pdf/7907/7907crc.pdf as .pdf]</ref> Treatment of primary RLS should not be considered unless all the secondary medical conditions are ruled out. Drug therapy in RLS is not curative and is  known to have significant side effects and needs to be considered with caution. The secondary form of RLS has the potential for cure if the  precipitating medical condition ([[iron deficiency]], venous reflux/[[varicose vein]], [[thyroid]], etc.) is managed effectively.

Revision as of 15:27, 10 June 2013

Restless legs syndrome
Sleep pattern of a Restless Legs Syndrome patient (red) vs. a healthy sleep pattern (blue).

Restless legs syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Restless legs syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Restless legs syndrome On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Restless legs syndrome

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Restless legs syndrome

CDC on Restless legs syndrome

Restless legs syndrome in the news

Blogs on Restless legs syndrome

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Restless legs syndrome

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Synonyms and keywords: Wittmaack-Ekbom's syndrome; RLS

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Restless legs syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Medical Therapy

See potential causal relationship between acidosis and RLS above in "Explanation." An algorithm for treating Primary RLS ( RLS without any secondary medical condition including iron deficiency, varicose vein, thyroid, etc.) was created by leading RLS researchers at the Mayo Clinic and is endorsed by the Restless Legs Syndrome Foundation. This document provides guidance to both the treating physician and the patient, and includes both nonpharmacological and pharmacological treatments.[1] Treatment of primary RLS should not be considered unless all the secondary medical conditions are ruled out. Drug therapy in RLS is not curative and is known to have significant side effects and needs to be considered with caution. The secondary form of RLS has the potential for cure if the precipitating medical condition (iron deficiency, venous reflux/varicose vein, thyroid, etc.) is managed effectively.

Iron supplements

All people with RLS should have their ferritin levels tested; ferritin levels should be at least 50 mcg for those with RLS. Oral iron supplements, taken under a doctor's care, can increase ferritin levels. For some people, increasing ferritin will eliminate or reduce RLS symptoms. A ferritin level of 50 mcg is not sufficient for some sufferers and increasing the level to 80 mcg may greatly reduce symptoms. However, at least 40% of people will not notice any improvement. Treatment with IV iron is being tested at the US Mayo Clinic and Johns Hopkins Hospital. It is dangerous to take iron supplements without first having ferritin levels tested, as many people with RLS do not have low ferritin and taking iron when it is not called for can cause iron overload disorder, potentially a very dangerous condition.

New results from the first ever double-blind clinical study,[2] performed at Örebro University Hospital show that all 29 out of 60 patients that were treated with IV-infusion of up to a total of 1000 mg of iron (in the form of iron saccharose, Venofer), were markedly improved after 3 weeks. The effect lasted for 5-6 months. Those 31 receiving placebo had just a slight effect after 3 weeks that additionally disappeared rapidly.

The treatment was given even if iron deficiency was not shown according to ferritin levels. Worries of anaphylactic reactions did not come true. This is probably due to the form the IV iron was given. Anaphylaxis has been associated predominantly with dextran based infusions.

Lifestyle changes and other non-medicinal approaches

Treatment for RLS is based on how disruptive the symptoms are. All people should review their lifestyle and see what changes could be made to reduce or eliminate their RLS symptoms. These include: finding the right level of exercise (too much worsens it, too little may trigger it); eliminating caffeine, smoking, and alcohol; changing the diet to eliminate foods that trigger RLS (different for each person, but may include eliminating sugar, triglycerides, gluten, sugar substitutes (aspartame), following a low-fat diet, etc.); keeping good sleep hygiene; treating conditions that may cause secondary RLS; avoiding or stopping OTC or prescription drugs that trigger RLS; adding supplements such as potassium, magnesium, B-12, folate, vitamin E, and calcium. Some of these changes, such as diet (particularly aspartame) and adding supplements are based on anecdotal evidence from RLS sufferers as few studies have been done on these alternatives.

For those who experience RLS infrequently and do not need or want to try medication, in addition to lifestyle changes they can try:

  • Some form of exercise for several minutes such as walking, stretching, meditation, yoga, etc. at bedtime
  • Heat or cold, such as a hot or cold bath, a heating pad, a cold cloth, or a fan
  • Soaking one's feet in hot water just prior to going to sleep
  • Engrossing the mind in a game, the computer, or figuring something out
  • Wearing compression stockings, tight pantyhose, or wrapping the legs in elastic bandages
  • Placing a pillow between the knees or upper-legs while lying in bed
  • Eating porridge oats or almonds daily for their magnesium content
  • Hot green tea can relieve symptoms
  • Deep breathing for one or two minutes
  • Massage and chiropractic spinal manipulation provide significant relief for some patients.

Medicinal approaches

For those whose RLS disrupts or prevents sleep or regular daily activities, medication is often required. Many Doctors currently use, and the Mayo Clinic Algorithm includes,[1] medication from four categories:

Agent Timeline Comments
ropinirole Approved In 2005 by the Food and Drug Administration to treat moderate to severe Restless Legs Syndrome The drug was first approved for Parkinson's disease in 1997.
pramipexole (Mirapex, Sifrol, Mirapexen in the EU) In February 2006, the EU Scientific Committee issued a positive recommendation for approving for the treatment of RLS in the EU. US FDA approved Mirapex in 2006. -
rotigotine Currently in process for US FDA and EU approval for RLS Delivered via a transdermal patch
pergolide In March 2007 was withdrawn from the U.S. market Withdrawn due to implication in valvular heart disease, that was shown in two independent studies.

There are some issues with the use of dopamine augmentation. Dopamine agonists may cause augmentation. This is a medical condition where the drug itself causes symptoms to increase in severity and/or occur earlier in the day. Dopamine agonists may also cause rebound, when symptoms increase as the drug wears off. Also, a recent study indicated that dopamine agonists used in restless leg patients can lead to an increase in compulsive gambling.[3]

In a study of 10 patients, it was reported that partial relief with taking a supplemental magnesium salt[4] such as magnesium oxide or magnesium gluconate once or twice a day, and reducing the dose if diarrhea develops. Magnesium sulfate is the most active form; however, magnesium supplementation can cause complications for patients with renal problems.[5]

Controversies

Recently, several major pharmaceutical companies are reported to be marketing drugs without an explicit approval for RLS, which are "off-label" applications for drugs approved for other diseases. The Restless Leg Foundation [6] received 44% of its $1.4 million in funding from these pharmaceutical groups[7]. This has called into question the neutrality of this group (significant conflict of interest issue) and the course of action which they recommend to RLS patients.

Related Chapters

References

  1. 1.0 1.1 Mayo Clinic Algorithm also available as .pdf
  2. "Järninfusioner minskar symtomen vid restless legs". Retrieved 2007-07-23.
  3. "Medical Therapy for Restless Legs Syndrome may Trigger Compulsive Gambling", Mayo Clinic in Rochester, February 08, 2007
  4. Hornyak M, Voderholzer U, Hohagen F, Berger M, Riemann D (1998). "Magnesium therapy for periodic leg movements-related insomnia and restless legs syndrome: an open pilot study". Sleep. 21 (5): 501–5. PMID 9703590.
  5. "Magnesium Supplements (Systemic) - MayoClinic.com". Retrieved 2007-08-08.
  6. * RLS Foundation
  7. Marshall, Jessica, and Peter Aldhous. "Patient Groups Special." New Scientist, 10/26/06

Template:Diseases of the nervous system

ca:Síndrome de les cames neguitoses de:Restless-Legs-Syndrom ms:Sindrom kaki resah fi:Levottomat jalat sv:Rastlösa ben

Template:WH Template:WS